PODCAST · health
Cognitio
by LifeSciences Australia
Welcome to Cognitio, the weekly podcast by LifeSciences Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve.Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting
Episodes
-
Enabling Leadership with Zak Huang
What if leadership is measured not by what you achieve, but by what becomes possible because of you? Physician and global regulatory leader Zak Huang shares his enabling leadership framework: elevate the thinking, remove the obstacles, build the capability. Drawing on a real BLA filing where a...
-
Making Safety Part of Drug Design
Why does fewer than one in ten drugs that enter clinical trials ever reach patients — and what can be done about it before a compound ever gets there? In this episode of Cognitio, Richard Knight, toxicologist and co-founder of Apconix, a nonclinical consultancy and lab working with biotech and...
-
Navigating Complexity: Multi-Site Governance and AI in Research Oversight
Ethics approval is only the first hurdle for a clinical trial. Every site then needs its own research governance review, and that can cost patients precious time. In this Clinical Trials Day webinar, Angela Scheppokat, Manager Governance at the Royal Melbourne Hospital Office for Research…
more -
Between Leadership and Dependence: Australia's HTA System Under Pressure
Australia occupies an unusual position in global pharmaceuticals. It is regarded as a leader in cost effectiveness assessment, and at the same time it depends on innovation funded largely elsewhere. What does that dual role mean for patient access and for the medicines that reach this market? In...
-
What the Coroners Know
Every year in England and Wales, coroners write around 450 reports naming actions that could prevent future deaths. Roughly one in five involves a medicine. They are public, they are searchable, and according to our guest, essentially no pharmaceutical company is using them for pharmacovigilance....
-
Draw It Before You Say It
Our sector speaks in technical language, and that language is precise, accurate and often impenetrable to the people it is meant to serve. In this episode of Cognitio, Tim Boyle hands the microphone to Jessamy Gee, founder and director of Think in Colour and Australia's first IFVP certified…
more -
How Do We Know It Isn't Just Luck? Biostatistics in Early Phase Trials
Every early phase trial ends with a number, and with a judgement about whether that number means anything. In this episode of Cognitio, Professor Rory Wolfe of the Monash University Clinical Trial Centre and medical statistician Dr Alan Herschtal set out how biostatistics underpins that…
more -
Invisible, Essential and Overloaded: Rethinking Medical Operations
Medical operations teams are often essential to the work of medical affairs, yet much of their contribution remains unseen. At the same time, growing workloads, limited resources and constant interruptions can leave teams operating in a cycle of reactive support. In this episode of Cognitio,...
-
Adoption of AI in Pharmacovigilance
Artificial intelligence is moving from experimentation into practical use across pharmacovigilance, but adoption brings important questions about accuracy, privacy, validation and accountability. In this episode of Cognitio, Ata Arkham, Senior Patient Safety Specialist at AstraZeneca, joins…
more -
Bringing Clinical Trials Closer to Home: Building a Regional Trial Service
Clinical trials can offer patients access to new treatments, but geography remains a major barrier for people living in rural, regional and remote communities. In this episode of Cognitio, Tim Boyle is joined by Katrina Orr and Nadine Herren from the WA Country Health Service Trial Centre. They...
-
From Discovery to Patient Impact: Perseverance, Integrity and the Path to Innovation
In this episode of Cognitio, the podcast of LifeSciences Australia, we revisit a conversation recorded at the 2025 Annual Conference with Associate Professor Pegah Varamini from the University of Sydney. A clinical pharmacist and cancer researcher, Pegah shares the personal and professional...
-
Paul Batten, ObjectivoData
In this BioBeacon edition of the Cognitio Podcast, ARCS CEO Tim Boyle speaks with Paul Batten, founder of ObjectivoData, about his unexpected journey from mechanical engineering and McLaren to clinical trial technology. Paul shares how working on a COVID-era telehealth trial exposed the need for...
-
Dr Daniel Beard, Founder and CSO ShearFlow
What if you could give a stroke patient more time? That is the question driving Dr Daniel Beard and the team at ShearFlow, a biotech spin-out from the University of Newcastle developed in joint venture with Harvard University. In this episode, ARCS intern Iqra sits down with Daniel to trace a...
-
AI Basics for Regulatory Professionals: Safe Use, Smart Prompting and Human Accountability
Artificial intelligence is already reshaping how regulatory professionals work—but with opportunity comes responsibility. In this episode of Cognitio, we bring you key insights from an ARCS webinar led by Kyle from GXP Vigilance, exploring how AI is being used across regulatory affairs,...
-
ARCS Weekly Wrap - 1 May 2026
This week on Top 3 with Tim, ARCS CEO Dr Tim Boyle shares the biggest updates shaping the ARCS community and Australia’s life sciences sector. In this short update: • Final call for 2026 ARCS Annual Conference early bird registrations • ARCS announces its new partnership with the Australian...
-
Signals to Clinical Evidence
How do we separate misinformation from meaningful public health signals, and what happens when digital intelligence is combined with clinical evidence? In this episode of Cognitio, we explore how online sentiment, AI-powered surveillance and real-world healthcare data can work together to…
more -
S02E10 High Performance, Hidden Challenges
What does high performance really look like when it’s shaped by lived experience? In this episode of Cognitio, we explore the intersection between professional capability and chronic illness—and how navigating personal health challenges can fundamentally shape resilience, leadership, and...
-
Teams First: Cultivating Resilient Leaders in Competitive Environments
What can elite sport teach us about leadership in the workplace? In this episode of the Cognitio Podcast, Tim Boyle sits down with Tomek Szklarski, Head Coach of the Australian National Handball Team, to explore how high-performance sporting environments develop resilient leaders, build trust…
more -
Designing with, not for: The Power of Patient Co-Creation
What does it really mean to design healthcare with patients? In this episode of the Cognitio Podcast, Georghien Wiley, ARCS Convener for the Patient Engagement Interest Area, leads a powerful and deeply personal discussion on patient co-creation. Through real-world experiences, this episode...
-
Reimbursement Pathways and Patient Access for Cell and Gene Therapies in Australia
Cell and gene therapies such as CAR-T are transforming modern medicine, offering new treatment options for cancers and rare diseases. But getting these breakthrough therapies to patients is not straightforward. In this episode of the Cognitio Podcast, Warwick Shaw from Johnson & Johnson explores...
-
ARCS Weekly Wrap 20 March 2026
Three signals this week point to a sector at a turning point. Australia’s life sciences industry is accelerating—with stronger local capability, growing global engagement, and a more coordinated national R&D strategy taking shape. But there’s a critical question we need to address. As we move...
-
Regulatory Guidelines Supporting Non-Animal Models in Pharmaceutical Development
In this episode of Cognitio, Tim Boyle speaks with Dr Natalie Anderson about the evolving regulatory landscape for non-animal models in pharmaceutical development. We explore global reforms at the US FDA and European Medicines Agency, the application of the Three Rs, and how Australia’s TGA is...
-
Why do smart professionals still freeze in high-pressure moments?
In this episode of Cognitio, ARCS CEO Tim Boyle explores the behavioural science behind leadership, compliance and decision-making in regulated environments. Despite extensive training and detailed SOPs, deviations still occur. So what’s missing? This conversation dives into the psychology of...
-
ARCS Weekly Wrap 6 March 2026
What are the three biggest developments shaping Australia’s life sciences sector this week? In this short weekly briefing, ARCS CEO Tim Boyle shares the top stories from across the medicines, medical devices and clinical research ecosystem. This week’s episode covers: • A major step toward...
-
From Trial to Market: Navigating Pharmacovigilance Case Management Differences
What changes when a therapy moves from clinical trials to the real world? In this episode of the Cognitio podcast, ARCS Australia CEO Tim Boyle speaks with Carl Bufe about the critical differences between clinical development safety management and post-market pharmacovigilance. From SUSAR…
more -
ARCS Weekly Wrap 27 February 2026
This week in Australian life sciences: a $1.6B digital health acquisition, global momentum in cell and gene therapy, AI in regulatory affairs, and registrations opening for the 2026 ARCS Annual Conference. In this short episode, Tim Boyle breaks down the top 3 stories shaping biotech, medtech,...
-
Cell & Gene Therapy in Australia: Are We Ready?
Cell and gene therapies are transforming medicine — from CAR-T in oncology to next-generation gene therapies targeting rare disease. Ahead of the ARCS–DIA Cell & Gene Therapy Summit, Tim Boyle and Anna Megalakakis unpack Australia’s advanced therapies landscape. They explore manufacturing...
-
ARCS Weekly Wrap 20 February 2026
This week’s ARCS sector update covers three major developments shaping Australia’s medtech and pharmaceutical landscape. We unpack the AMR 2026 Summit in Sydney and the release of the Sixth AURA Report, highlighting why antimicrobial resistance is now an economic and national resilience issue. We...
-
South Korea: An Emerging Powerhouse in Clinical Trials and Pharmacovigilance
South Korea has rapidly established itself as one of the world’s leading destinations for clinical research. With dense urban populations, advanced hospital infrastructure and a highly structured regulatory framework, it is now consistently ranked among the top countries globally for clinical…
more -
ARCS Weekly Wrap 13 February 2026
Global recognition for the TGA. PBS tensions escalating into legal action. And major leadership shifts across pharma. In this episode, Tim Boyle breaks down the three biggest stories shaping Australia’s life sciences sector this week — and why they matter for regulatory affairs, market access,...
-
Advancing LGBTQIA+ Inclusion in Healthcare
Advancing LGBTQIA+ Inclusion in Healthcare and Research In this episode of Cognitio, ARCS Australia CEO Tim Boyle explores why LGBTQIA+ inclusion is no longer optional in healthcare, clinical research, and the life sciences sector. Drawing on insights from an ARCS webinar featuring guests from...
-
ARCS Weekly Wrap 6 February 2026
A big week for policy, funding and medicine access. In this episiode, I break down my top three life sciences stories for the week and why they matter for Australia’s sector. ARCS members get the full weekly briefing via email. Join ARCS to stay across what matters.
-
ARCS Weekly Wrap 5th December 2025
🎙️ ARCS Weekly News Wrap — Final Episode of 2025 Tim and Anna team up for the final Weekly News Wrap of the year, bringing you the most significant stories shaping Australia’s life sciences landscape. This fast, engaging episode covers the biggest pharma leadership moves, biotech breakthroughs,...
-
Yarning Up Research: shifting from “done to” to “done with” in Aboriginal health trials
Inclusive clinical research is not a box to tick. It is a way of working. In this episode of the Cognitio Podcast, Tim Boyle is joined by webinar presenters Jane Gaunson, Olivia Payne, Mariam Hachem and Bernard Kelly-Edwards to explore practical strategies for partnering with Aboriginal and…
more -
ARCS Weekly Wrap 28 November 2025
In this week’s ARCS Weekly News Wrap, Tim Boyle unpacks the headlines shaping Australia’s medicines, medtech and biotech sectors, with a sharp eye on what they mean for professionals working across the product lifecycle. We cover key policy and reimbursement signals, regulatory and manufacturing...
-
Heart of Australia
In this episode of the Cognitio Podcast, Tim Boyle introduces a powerful conversation on innovation, access, and equity in clinical trials. Featuring Julia Linda from Eli Lilly Australia and Melissa Reilly from Heart of Australia, the episode explores how clinical research can be delivered to...
-
ARCS Weekly Wrap 21 November 2025
In this week’s ARCS Weekly News Wrap, Tim Boyle recaps a major week for Australia’s life sciences sector during National Clinical Trials Week. The episode covers key developments across pharma, medtech, biotech, policy and investment, along with insights from ARCS’ activities in Melbourne,...
-
Pharmacovigilance and Equity: Medicine Safety for First Nations Communities
In this episode of the Cognitio Podcast, host Tim Boyle explores one of the most critical equity challenges in Australian healthcare: ensuring safe, effective, culturally informed use of medicines for First Nations peoples. Tim is joined by four respected leaders in medicine safety: Karen Battat...
-
ARCS Weekly Wrap 14 November 2025
This week’s wrap brings you the biggest developments across Australia’s life sciences sector — all in one quick, engaging update. We cover major pharma moves, medtech breakthroughs, biotech investment momentum, regulatory updates, and the latest people movements shaping the industry. From gene...
-
What is Intellectual Property?
What is Intellectual Property? A Practical Guide for Australia’s Life Sciences Sector In this episode of Cognitio, Tim Boyle takes listeners on a clear and engaging tour of the intellectual property landscape, guided by three specialists from Spruson and Ferguson Lawyers. IP sits at the core of...
-
ARCS Weekly Wrap 7th November 2025
In this week’s episode, Anna Megalakakis steps behind the mic to bring you a fast-paced and insightful roundup of the biggest developments across Australia’s life sciences sector. From blockbuster pharma shifts and cutting-edge medtech launches to biotech investment momentum and major leadership...
-
AI in Regulatory Affairs: From Burden to Breakthrough
In this episode of The Cognitio Podcast, ARCS Australia CEO Tim Boyle introduces highlights from a thought-provoking ARCS Interest Area webinar, Automating Life Science Workflows through AI, presented by Dr Rishi Verma, CEO and Founder of Stethy AI. Dr Verma, a physician and engineer, takes...
-
ARCS Weekly Wrap 31st October 2025
This week’s episode dives into the biggest stories shaping Australia’s life sciences landscape — from global leadership milestones to biotech breakthroughs and policy reform. We celebrate Professor Tony Lawler’s appointment as Global Chair of the International Coalition of Medicines Regulatory...
-
Next Generation Nuclear Medicine
Next Generation Nuclear Medicine: Powering the Future of Precision Health In this episode of ARCS Cognitio, ARCS Australia CEO Tim Boyle leads a compelling conversation on the rapidly evolving world of next-generation nuclear medicines — where physics meets biology to transform how we diagnose…
more -
ARCS Weekly Wrap 24th October 2025
ARCS Weekly News Wrap – Week Ending 25 October 2025 This week’s episode covers a powerhouse mix of policy shifts, scientific breakthroughs, and leadership changes shaping Australia’s life sciences landscape. Join Tim Boyle, CEO of ARCS Australia, as he unpacks: Pharma: Landmark PBS listings,...
-
ARCS Weekly Wrap 17 October 2025
In this week’s ARCS Weekly News Wrap, Tim Boyle returns from Adelaide after the KCA Conference to bring you the top stories shaping Australia’s life sciences sector. This episode covers: • Pharma: FDA approval for MSD’s subcutaneous Keytruda, Eli Lilly’s oral obesity drug heading to the TGA, and...
-
ARCS Weekly Wrap 26 September 2025
This week’s ARCS Weekly News Wrap dives into the biggest stories shaping pharma, medtech, biotech, and the workforce behind them. From the MAPA-MAPS Summit and student careers fairs to global debates over paracetamol, robotic surgery innovations, and major biotech funding deals — we break it all...
-
Market Access - Devices vs Medicines
In this episode of the Cognitio Podcast, Goce Bogeski FMPP shares his reflections on the often-overlooked similarities between pharmaceuticals and medical devices. Drawing on years of experience across both fields, he explains how market access processes converge, where inefficiencies exist, and...
-
ARCS Weekly Wrap 19 September 2026
Weekly News Wrap – 19 September 2025 This week’s ARCS Weekly News Wrap is packed with sector-shaping stories across pharma, medtech, biotech, and leadership. Tim Boyle recaps a milestone few days for ARCS, including a sold-out Leadership & Communications Symposium and a record turnout at our...
-
Unpacking the R&D Tax Incentive for the Australian LifeSciences sector
Australia’s R&D Tax Incentive is one of the most significant programs driving investment and innovation in the life sciences. But how does it really work in practice, and what do the latest transparency data tell us about the companies claiming it? In this episode of the ARCS Cognitio Podcast…
more
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Welcome to Cognitio, the weekly podcast by LifeSciences Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve.Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting
HOSTED BY
LifeSciences Australia
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Cognitio have?
Cognitio currently has 66 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Cognitio about?
Welcome to Cognitio, the weekly podcast by LifeSciences Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, this podcast delivers bite-sized updates, expert discussions, and professional development insights to...
How often does Cognitio release new episodes?
Cognitio has 66 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Cognitio?
You can listen to Cognitio on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Cognitio?
Cognitio is created and hosted by LifeSciences Australia.
URL copied to clipboard!